HY-101986-10mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-100mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-25mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-5mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-101986-50mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-102071-10mg
|
MedChemexpress LLC
|
KIN59 [CAS 4152-77-6]
|
|
|
|
HY-102071-5mg
|
MedChemexpress LLC
|
KIN59 [CAS 4152-77-6]
|
|
|
|
HY-10254-10mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-100mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-25mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-5mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-50mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-107471-10mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-100mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-25mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-5mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-50mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-114544A-10mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
HY-114544A-100mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
HY-114544A-5mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
HY-114544A-50mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
HY-118798-10mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
HY-118798-25mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
HY-118798-5mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
HY-119539-10mg
|
MedChemexpress LLC
|
Limocitrin [CAS 489-33-8]
|
|
|
|